Project Number ADDF-54 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2022 View Full Project Details for Development of cell free messenger RNA-based non-invasive diagnostic biomarker for Alzheimer's disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category B. Diagnosis, Assessment, and Disease Monitoring 1. Fluid Biomarkers b. Blood-based Biomarkers Researcher and Organization Principal Investigator Sninsky, John Principal Investigator Sninsky, John Awardee Organization Molecular Stethoscope, Inc. Awardee State California Contact PI Country United States Project Detail Funding Opportunity Announcement ADDF-Neuroimaging and CSF Biomarkers Program FY Overall Cost $1,820,426 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States Program Official ADDF Grants Management